Inventor · disambiguated record
Bert Tsunyin Lai
Also filed as: LAI BERT TSUNYIN
6 granted patents·3 pending applications·18 citations·filing 2016–2023
75Inventor score
Top patents by PatentIndex Score
9 records- 0191US10598671B2IL-17F-specific capture agents, compositions, and methods of using and makingCALIFORNIA INST OF TECHN·Filed 2016·Granted Mar 24, 2020·13 cites·50 claims
- 0290US11733246B2Compositions, imaging, and therapeutic methods targeting folate receptor 1 (FOLR1)INDI MOLECULAR INC·Filed 2022·Granted Aug 22, 2023·2 cites·30 claims
- 0389US11766414B2Compositions, delivery systems, and methods useful in tumor therapyINDI MOLECULAR INC·Filed 2022·Granted Sep 26, 2023·2 cites·25 claims
- 0474US11719705B2IL-17F and IL-17A-specific capture agents, compositions, and methods of using and makingINDI MOLECULAR INC·Filed 2018·Granted Aug 8, 2023·1 cites·40 claims
- 0568US2024053349A1Compositions, imaging, and therapeutic methods targeting folate receptor 1 (folr1)INDI MOLECULAR INC·Filed 2023·Application pending·0 cites
- 0668US2024180856A1Compositions, delivery systems, and methods useful in tumor therapyINDI MOLECULAR INC·Filed 2023·Application pending·0 cites
- 0750US12216122B2Compositions and methods relating to detection, inhibition, and imaging of indoleamine 2,3-dioxygenase 1 (IDO1)REGENERON PHARMA·Filed 2020·Granted Feb 4, 2025·0 cites·17 claims
- 0844US2020291391A1Cross-linked epitopes and methods of use thereofINDI MOLECULAR INC·Filed 2020·Application pending·0 cites
- 0941US11884707B2Compositions for detection, inhibition and imaging of indoleamine 2, 3-dioxygenase 1 (IDO1) and methods of making and using sameREGENERON PHARMA·Filed 2017·Granted Jan 30, 2024·0 cites·26 claims
Join the waitlist — get patent alerts
Get an alert when Bert Tsunyin Lai files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →